Form D · Biotechnology
Arcturus Therapeutics, Inc.
San Diego, CA · CIK 0001573745
Offering snapshot reported Oct 27, 2015 · SEC filing
- Reported sold
- $5.92M Offering amount: $10M
- Investors reported
- 43 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 1, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 27, 2015 | Initial | $5,924,500 | No comparison | 43 | SEC filing |
| Dec 18, 2013 | Initial | $4,636,355 | No comparison | 18 | SEC filing |
| Sep 30, 2013 | Initial | $2,135,355 | No comparison | 11 | SEC filing |
| Apr 5, 2013 | Initial | $580,001 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-250132
Source: Form D, filed Oct 27, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Padmanabh Chivukula | Director, Executive |
| Joseph Edward Payne | Director, Executive |
| Craig Willett | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10628 Science Center Drive, Suite 200
San Diego, CA, 92121
San Diego, CA, 92121